Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling
Open Access
- 1 April 2024
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 10 (2) , e12471
Abstract
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by declines in cognitive and functional severities. This research utilized the Clinical Dementia Rating (CDR) to assess the influence of tilavonemab on these deteriorations. METHODS: Longitudinal Item Response Theory (IRT) models were employed to analyze CDR domains in early‐stage AD patients. Both unidimensional and multidimensional models were contrasted to elucidate the trajectories of cognitive and functional severities. RESULTS: We observed significant temporal increases in both cognitive and functional severities, with the cognitive severity deteriorating at a quicker rate. Tilavonemab did not demonstrate a statistically significant effect on the progression in either severity. Furthermore, a significant positive association was identified between the baselines and progression rates of both severities. DISCUSSION: While tilavonemab failed to mitigate impairment progression, our multidimensional IRT analysis illuminated the interconnected progression of cognitive and functional declines in AD, suggesting a comprehensive perspective on disease trajectories. Highlights: Utilized longitudinal Item Response Theory (IRT) models to analyze the Clinical Dementia Rating (CDR) domains in early‐stage Alzheimer's disease (AD) patients, comparing unidimensional and multidimensional models. Observed significant temporal increases in both cognitive and functional severities, with cognitive severity deteriorating at a faster rate, while tilavonemab showed no statistically significant effect on either domain's progression. Found a significant positive association between the baseline severities and their progression rates, indicating interconnected progression patterns of cognitive and functional declines in AD. Introduced the application of multidimensional longitudinal IRT models to provide a comprehensive perspective on the trajectories of cognitive and functional severities in early AD, suggesting new avenues for future research including the inclusion of time‐dependent random effects and data‐driven IRT models.Keywords
Funding Information
- National Institute on Aging (AG064803, P30AG072958)
This publication has 32 references indexed in Scilit:
- Gender‐, age‐, and race/ethnicity‐based differential item functioning analysis of the movement disorder society–sponsored revision of the Unified Parkinson's disease rating scaleMovement Disorders, 2016
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s diseaseNature, 2016
- Item response analysis of Alzheimer's disease assessment scale2014
- Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric ModelingPharmaceutical Research, 2014
- Improved Statistical Power of Alzheimer Clinical Trials by Item-Response TheoryAlzheimer Disease & Associated Disorders, 2013
- Subjective Cognitive Complaints of Older Adults at the Population LevelAlzheimer Disease & Associated Disorders, 2012
- Gaining precision on the Alzheimer's Disease Assessment Scale‐cognitive: A comparison of item response theory‐based scores and total scoresAlzheimer's & Dementia, 2012
- Greater Precision when Measuring Dementia Severity: Establishing Item Parameters for the Clinical Dementia Rating ScaleDementia and Geriatric Cognitive Disorders, 2012
- Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysisInternational Psychogeriatrics, 2011
- The Clinical Dementia Rating (CDR)Neurology, 1993